Cargando…
Limits of Monoclonal Antibody Treatment in Pregnant Women Complicated with COVID-19 Due to The Omicron Variant
Autores principales: | Cha, Hyun-Hwa, Kim, Sujeong, Kim, Hyun Mi, Kim, Mi Ju, Seong, Won Joon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Infectious Diseases; Korean Society for Antimicrobial Therapy; The Korean Society for AIDS
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259917/ https://www.ncbi.nlm.nih.gov/pubmed/35706072 http://dx.doi.org/10.3947/ic.2022.0034 |
Ejemplares similares
-
Impact of vaccination and the omicron variant on COVID-19 severity in pregnant women
por: Kim, Haemin, et al.
Publicado: (2023) -
Diagnosis of gestational diabetes: Are five rounds of blood sampling necessary?
por: Cha, Hyun-Hwa, et al.
Publicado: (2022) -
Prediction of maternal complications and neonatal outcome in dichorionic diamniotic twins with fetal weight discordancy measured by ultrasonography
por: Kim, Hyun Mi, et al.
Publicado: (2022) -
Omicron sublineage BQ.1.1 resistance to monoclonal antibodies
por: Arora, Prerna, et al.
Publicado: (2023) -
Omicron Variant Escapes Therapeutic Monoclonal Antibodies (mAbs) Including Recently Released Evusheld(®), Contrary to 8 Prior Main Variant of Concern (VOC)
por: Boschi, Céline, et al.
Publicado: (2022)